The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

A panelist discusses how she carefully transitions patients to neurokinin-targeted therapies by establishing realistic timelines for symptom improvement and actively monitoring patient response while ...

In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...

Leaders from the WHO responded with a statement saying that the organization hopes the United States will reconsider. “WHO ...